These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 39082332)

  • 1. An Apoptosis-Related Specific Risk Model for Breast Cancer: From Genomic Analysis to Precision Medicine.
    Li Z; Liu H; Zhang M; Wang J; Peng Q; Jiang N; Wei Y
    Front Biosci (Landmark Ed); 2024 Jun; 29(7):239. PubMed ID: 39082332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Develop a Novel Signature to Predict the Survival and Affect the Immune Microenvironment of Osteosarcoma Patients: Anoikis-Related Genes.
    Yang M; Su Y; Xu K; Zheng H; Cai Y; Wen P; Yang Z; Liu L; Xu P
    J Immunol Res; 2024; 2024():6595252. PubMed ID: 39431237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
    Wang Z; Liu H; Gong Y; Cheng Y
    Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anoikis-related genes in breast cancer patients: reliable biomarker of prognosis.
    Tang M; Rong Y; Li X; Pan H; Tao P; Wu Z; Liu S; Tang R; Liu Z; Cai H
    BMC Cancer; 2024 Sep; 24(1):1163. PubMed ID: 39300389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
    BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of a bladder cancer risk model based on autophagy-related genes.
    Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H
    Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
    Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J
    Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prognostic model for hepatocellular carcinoma based on apoptosis-related genes.
    Liu R; Wang G; Zhang C; Bai D
    World J Surg Oncol; 2021 Mar; 19(1):70. PubMed ID: 33712023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a novel prognostic signature based on single-cell combined bulk RNA analysis in breast cancer.
    Xiao Y; Hu G; Xie N; Yin L; Pan Y; Liu C; Lou S; Zhu C
    J Gene Med; 2024 Feb; 26(2):e3673. PubMed ID: 38404059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancer.
    Shen C; Chai W; Han J; Zhang Z; Liu X; Yang S; Wang Y; Wang D; Wan F; Fan Z; Hu H
    Front Immunol; 2023; 14():1213947. PubMed ID: 37965307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial-related genes as prognostic and metastatic markers in breast cancer: insights from comprehensive analysis and clinical models.
    Fang Y; Zhang Q; Guo C; Zheng R; Liu B; Zhang Y; Wu J
    Front Immunol; 2024; 15():1461489. PubMed ID: 39380996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PANoptosis-related molecular clustering and prognostic signature associated with the immune landscape and therapy response in breast cancer.
    Cao Y; Guan L; Yang L; Wei C
    Medicine (Baltimore); 2024 Sep; 103(37):e39511. PubMed ID: 39287311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel TCGA-validated programmed cell-death-related signature of ovarian cancer.
    Cai X; Lin J; Liu L; Zheng J; Liu Q; Ji L; Sun Y
    BMC Cancer; 2024 Apr; 24(1):515. PubMed ID: 38654239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
    Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z
    JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and validation of an aging-related gene signature for prognosis prediction of patients with breast cancer.
    Li J; Qi C; Li Q; Liu F
    Cancer Rep (Hoboken); 2023 Mar; 6(3):e1741. PubMed ID: 36323529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a mitotic catastrophe-related genes prognostic model for breast cancer.
    Wang S; Zi H; Li M; Kong J; Fan C; Bai Y; Sun J; Wang T
    PeerJ; 2024; 12():e18075. PubMed ID: 39314848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and validation of a prognostic model of angiogenesis-related genes in multiple myeloma.
    Hu R; Chen F; Yu X; Li Z; Li Y; Feng S; Liu J; Li H; Shen C; Gu X; Lu Z
    BMC Cancer; 2024 Oct; 24(1):1269. PubMed ID: 39394121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.